VFEND
Google image searchProduct monograph
Active ingredient
voriconazole, 200 MG/5 ML
DIN: 02279991
Dosage form(s): POWDER FOR SUSPENSION
Route(s) of administration: ORAL
Schedule: Prescription
Company: PFIZER CANADA ULC
Date: 17-JUL-2008
ATC:
- J02 — ANTIMYCOTICS FOR SYSTEMIC USE (ATC, ATC/DDD, )
- J02A — ANTIMYCOTICS FOR SYSTEMIC USE (ATC, ATC/DDD)
- J02AC — Triazole derivatives (ATC, ATC/DDD)
- J02AC03 — VORICONAZOLE (ATC/DDD)
Reference brand drug: Vfend
Pharmaceutical standard: MFR
